We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Teachable Moment | 
Simran Kaur Matta, MD; Alan Greenberg, MD; Aditi Singh, MD
JAMA Intern Med. 2015;175(11):1746-1747. doi:10.1001/jamainternmed.2015.4792.

Research Letter | 
Tamar Krishnamurti, PhD; Steven Woloshin, MD, MS; Lisa M. Schwartz, MD, MS; et al.
JAMA Intern Med. 2015;175(11):1856-1858. doi:10.1001/jamainternmed.2015.5355.

Research Letter |  ONLINE FIRST
Chul Kim, MD, MPH; Vinay Prasad, MD, MPH
JAMA Intern Med. Published online October 19, 2015. doi:10.1001/jamainternmed.2015.5868

Original Investigation | 
Vinay Prasad, MD, MPH; Chul Kim, MD, MPH; Mauricio Burotto, MD; et al.
JAMA Intern Med. 2015;175(8):1389-1398. doi:10.1001/jamainternmed.2015.2829.
Includes: Supplemental Content

Special Communication | 
Gary Schwitzer, BA
JAMA Intern Med. 2014;174(7):1183-1186. doi:10.1001/jamainternmed.2014.1359.
Includes: Supplemental Content

Viewpoint | 
Susan Desmond-Hellmann, MD, MPH
JAMA Intern Med. 2013;173(12):1051-1052. doi:10.1001/jamainternmed.2013.826.

Original Investigation |  FREE
Gregg H. Goldin, MD; Nathan C. Sheets, MD; Anne-Marie Meyer, PhD; et al.
JAMA Intern Med. 2013;173(12):1136-1143. doi:10.1001/jamainternmed.2013.1020.
Includes: Supplemental Content

Invited Commentary | 
Matthew R. Cooperberg, MD, MPH
JAMA Intern Med. 2013;173(12):1143-1144. doi:10.1001/jamainternmed.2013.6755.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Dermatology
Observation  | 
Complete Remission of Squamous Cell Carcinoma After Treatment With Panitumumab in a Patient With Cetuximab-Induced Anaphylaxis
Aurélie Marti, MS; Antoine Fauconneau, MD; Nora Ouhabrache, MD; et al.
JAMA Dermatology
Viewpoint  | 
Innovative New Drugs for Serious Nonlethal Diseases The Cost to Develop and the Cost to Buy
William H. Eaglstein, MD
JAMA Ophthalmology
Original Investigation  | 
Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
John A. Wells, MD; Adam R. Glassman, MS; Lee M. Jampol, MD; et al.
JAMA Oncology
From The JAMA Network  | 
Surrogates for Survival or Other End Points in Oncology
Michael LeBlanc, PhD; Catherine Tangen, DrPH